![Jean-Gabriel Judde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Gabriel Judde
Gründer bei XenTech SAS
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Pascal Leuraud | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | 18 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Arnaud Beurdeley | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Marie-Emmanuelle Legrier | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Bertrand Coulomb | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Jean-Marc Husson | M | - |
Université Paris Diderot-Paris 7
| 3 Jahre |
Delphine Nicolle | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Ludovic Bourre | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Sabrina Serpillon | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Paola Bazzacco | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Jerome Cheng | M | 70 |
Université Paris Diderot-Paris 7
| 4 Jahre |
Antoine Petit | M | 64 |
Université Paris Diderot-Paris 7
| 3 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Frankreich | 11 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Jean-Gabriel Judde
- Persönliches Netzwerk